Myocardial Damage and Music Study (MYDA-MUSIC)
Primary Purpose
Chronic Stable Angina, PTCA
Status
Unknown status
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
HRV-BASED MUSIC
Sponsored by
About this trial
This is an interventional prevention trial for Chronic Stable Angina
Eligibility Criteria
Inclusion Criteria:
- Chronic stable angina scheduled to undergo a coronary angiography and ad-hoc angioplasty
Exclusion Criteria:
- Abnormal c-TnI level before angiography
- Participation in other clinical studies
- Patients with pacemakers or defibrillators
- High rate atrial fibrillation (baseline heart rate >99 bpm) at enrolment
Sites / Locations
- San Filippo Neri General HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
MUSIC
DUMB EARPHONES
Arm Description
Music will be administered through a normal computer equipped with a technology (Sound-of-Soul) that translates the patient's heart rate variability (HRV) into sounds according to a digital computer music-library. Music will start 10 minutes before and will end at the completion of the interventional procedure
Dumb earphones will be placed over patient's ears starting 10 minutes before and ending at the completion of the interventional procedure.
Outcomes
Primary Outcome Measures
Incidence of procedure-related myocardial injury
c-TnI concentration >99th percentile URL in at least 1/3 blood drawings
Secondary Outcome Measures
Overall satisfaction with the procedure
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
Difference in Distress self-evaluation baseline and after the intervention
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
Evaluation of pain experienced during the interventional procedure
Self-evaluation test (score range 1-10, higher pain for higher values)
Difference in Anxiety evaluation baseline and after the intervention
State-Trait Anxiety Inventory (STAI) test - Y italian version (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales)
Questionnaire regarding a narrative report of the procedure
Categorical analysis evaluated with a dedicated software analysing unstructured written narration of the experience of their invasive procedure.
Changes in Mean Heart rate during the procedure (Heart rate variability measure)
Calculation of Mean HR (beats/minute) on ECG samples recorded for 5 to 10 minutes
Changes in RR during the procedure (Heart rate variability measure)
Calculation of Mean RR interval (msec) on 5 to 10 minutes duration ECG samples.
Changes in SDNN during the procedure (Heart rate variability measure)
Calculation of SDNN (msec) on 5 to 10 minutes duration ECG samples.
Changes in RMSSD during the procedure (Heart rate variability measure)
Calculation of RMSSD (msec) on 5 to 10 minutes duration ECG samples.
Changes in pNN50 during the procedure (Heart rate variability measure)
Calculation of pNN50 (%) on 5 to 10 minutes duration ECG samples.
Changes in pNN20 during the procedure (Heart rate variability measure)
Calculation of pNN20 (%) on 5 to 10 minutes duration ECG samples.
Changes in pNN10 during the procedure (Heart rate variability measure)
Calculation of pNN10 (%) on 5 to 10 minutes duration ECG samples.
Changes in pNN05 during the procedure (Heart rate variability measure)
Calculation of pNN05 (%) on 5 to 10 minutes duration ECG samples.
Changes in SD1 during the procedure (Heart rate variability measure)
Calculation of SD1 (msec) on 5 to 10 minutes duration ECG samples.
Changes in SD2 during the procedure (Heart rate variability measure)
Calculation of SD2 (msec) on 5 to 10 minutes duration ECG samples.
Changes in SD1/SD2 during the procedure (Heart rate variability measure)
Calculation of SD1/SD2 ratio (number) on 5 to 10 minutes duration ECG samples.
Changes in VB during the procedure (Heart rate variability measure)
Calculation of VB (sec) on 5 to 10 minutes duration ECG samples.
Changes in Stress index during the procedure (Heart rate variability measure)
Calculation of stress index (number) on 5 to 10 minutes duration ECG samples.
Changes in CV during the procedure (Heart rate variability measure)
Calculation of CV (number) on 5 to 10 minutes duration ECG samples.
Changes in Power of frequency domains during the procedure (Heart rate variability measure)
Calculation of the power of VLF, LF, HF and total frequency-domain power on 5 to 10 minutes duration ECG samples (ms2)
Postprocedural c-TnI peak concentration in patients undergoing coronary angioplasty
Highest concentration in c-TnI in 3 blood samples
Time-to-peak in c-TnI concentration in patients undergoing coronary angioplasty
Time-to-Highest concentration in c-TnI in 3 blood samples
Incidence of procedure-related myocardial infarction (myocardial infarction type 4a) in patients undergoing coronary angioplasty
c-TnI concentration >10 x the 99th percentile in at least 1/3 blood drawings
Incidence of in-hospital Major Adverse Cardiac Events in patients undergoing coronary angioplasty
Incidence of death, myocardial infarction, unplanned revascularization
Full Information
NCT ID
NCT03507361
First Posted
March 26, 2018
Last Updated
April 2, 2019
Sponsor
San Filippo Neri General Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03507361
Brief Title
Myocardial Damage and Music Study
Acronym
MYDA-MUSIC
Official Title
Heart Rate Variability-based Music for the Prevention of PCI-related Myocardial Injury
Study Type
Interventional
2. Study Status
Record Verification Date
April 2019
Overall Recruitment Status
Unknown status
Study Start Date
May 2, 2018 (Actual)
Primary Completion Date
May 2021 (Anticipated)
Study Completion Date
December 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
San Filippo Neri General Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
MYDA-MUSIC study is a randomized, double blind (operator and analyst) study performed in San Filippo Neri Hospital, Roma, Italy and in Di Venere Hospital, Bari, Italy. The planned study duration is 12 months. The objectives are to assess the effects of heart-rate-variability based music on the incidence and magnitude of peri-procedural myocardial damage caused by coronary angioplasty in stable patients. 443 patients with chronic stable angina scheduled for a coronary angiography and possible ad hoc angioplasty will be randomized to receive music or dumb earphones.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Stable Angina, PTCA
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
443 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
MUSIC
Arm Type
Experimental
Arm Description
Music will be administered through a normal computer equipped with a technology (Sound-of-Soul) that translates the patient's heart rate variability (HRV) into sounds according to a digital computer music-library. Music will start 10 minutes before and will end at the completion of the interventional procedure
Arm Title
DUMB EARPHONES
Arm Type
No Intervention
Arm Description
Dumb earphones will be placed over patient's ears starting 10 minutes before and ending at the completion of the interventional procedure.
Intervention Type
Other
Intervention Name(s)
HRV-BASED MUSIC
Intervention Description
Music is produced by Sound-of-Soul technology that translates HRV power frequency spectrum real-time into music. The intervals between the heartbeats are detected in milliseconds and then transferred into a frequency spectrum. Sound of Soul system gets wired into different band pass filters which are linked to the frequencies of the heart (i.e. low frequency and high frequency). Once the signal is detected and computed, the Sound of Soul system links it through a musical instrument digital interface (MIDI). This interface transforms ECG data into music and sounds. The audio production is performed using a virtual instrumentation technology with different music libraries. For the puropose of this study, all patients will ear the same instrument (arp). Once the instrument have been selected, the ECG gets recorded and in real-time the patient can hear a music obtained from his/her own HRV. The investigator will control the volume and the different settings of the music.
Primary Outcome Measure Information:
Title
Incidence of procedure-related myocardial injury
Description
c-TnI concentration >99th percentile URL in at least 1/3 blood drawings
Time Frame
within 24 hours from interventional procedure
Secondary Outcome Measure Information:
Title
Overall satisfaction with the procedure
Description
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
Time Frame
From 5 to 30 minutes after the interventional procedure
Title
Difference in Distress self-evaluation baseline and after the intervention
Description
Self-evaluation test on an analogic visual scale (score range 1-10, higher stress for higher values)
Time Frame
Baseline and from 5 to 30 minutes after the interventional procedure
Title
Evaluation of pain experienced during the interventional procedure
Description
Self-evaluation test (score range 1-10, higher pain for higher values)
Time Frame
Baseline and from 5 to 30 minutes after the interventional procedure
Title
Difference in Anxiety evaluation baseline and after the intervention
Description
State-Trait Anxiety Inventory (STAI) test - Y italian version (score range 20-80, the higher the score the more anxiety the patients has, 2 subscales)
Time Frame
Baseline and from 5 to 30 minutes after the interventional procedure
Title
Questionnaire regarding a narrative report of the procedure
Description
Categorical analysis evaluated with a dedicated software analysing unstructured written narration of the experience of their invasive procedure.
Time Frame
From 5 to 30 minutes after the interventional procedure
Title
Changes in Mean Heart rate during the procedure (Heart rate variability measure)
Description
Calculation of Mean HR (beats/minute) on ECG samples recorded for 5 to 10 minutes
Time Frame
Baseline and at 5 minutes intervals (recorded for 5 to 10 minutes)
Title
Changes in RR during the procedure (Heart rate variability measure)
Description
Calculation of Mean RR interval (msec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in SDNN during the procedure (Heart rate variability measure)
Description
Calculation of SDNN (msec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in RMSSD during the procedure (Heart rate variability measure)
Description
Calculation of RMSSD (msec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in pNN50 during the procedure (Heart rate variability measure)
Description
Calculation of pNN50 (%) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in pNN20 during the procedure (Heart rate variability measure)
Description
Calculation of pNN20 (%) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in pNN10 during the procedure (Heart rate variability measure)
Description
Calculation of pNN10 (%) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in pNN05 during the procedure (Heart rate variability measure)
Description
Calculation of pNN05 (%) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in SD1 during the procedure (Heart rate variability measure)
Description
Calculation of SD1 (msec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in SD2 during the procedure (Heart rate variability measure)
Description
Calculation of SD2 (msec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in SD1/SD2 during the procedure (Heart rate variability measure)
Description
Calculation of SD1/SD2 ratio (number) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in VB during the procedure (Heart rate variability measure)
Description
Calculation of VB (sec) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in Stress index during the procedure (Heart rate variability measure)
Description
Calculation of stress index (number) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in CV during the procedure (Heart rate variability measure)
Description
Calculation of CV (number) on 5 to 10 minutes duration ECG samples.
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Changes in Power of frequency domains during the procedure (Heart rate variability measure)
Description
Calculation of the power of VLF, LF, HF and total frequency-domain power on 5 to 10 minutes duration ECG samples (ms2)
Time Frame
Baseline and at 5 minutes intervals (5 to 10 minutes duration)
Title
Postprocedural c-TnI peak concentration in patients undergoing coronary angioplasty
Description
Highest concentration in c-TnI in 3 blood samples
Time Frame
within 24 hours from interventional procedure
Title
Time-to-peak in c-TnI concentration in patients undergoing coronary angioplasty
Description
Time-to-Highest concentration in c-TnI in 3 blood samples
Time Frame
within 24 hours from interventional procedure
Title
Incidence of procedure-related myocardial infarction (myocardial infarction type 4a) in patients undergoing coronary angioplasty
Description
c-TnI concentration >10 x the 99th percentile in at least 1/3 blood drawings
Time Frame
within 24 hours from interventional procedure
Title
Incidence of in-hospital Major Adverse Cardiac Events in patients undergoing coronary angioplasty
Description
Incidence of death, myocardial infarction, unplanned revascularization
Time Frame
Through study completion (average of 3 days)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Chronic stable angina scheduled to undergo a coronary angiography and ad-hoc angioplasty
Exclusion Criteria:
Abnormal c-TnI level before angiography
Participation in other clinical studies
Patients with pacemakers or defibrillators
High rate atrial fibrillation (baseline heart rate >99 bpm) at enrolment
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Christian Pristipino, MD
Phone
0633062504
Email
pristipino.c@gmail.com
Facility Information:
Facility Name
San Filippo Neri General Hospital
City
Roma
State/Province
RM
ZIP/Postal Code
00152
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Christian Pristipino, MD
Phone
00390633061
Email
pristipino.c@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Myocardial Damage and Music Study
We'll reach out to this number within 24 hrs